Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dylan Chapeau"'
Autor:
Dylan Chapeau, Savanne Beekman, Maryana Handula, Erika Murce, Corrina de Ridder, Debra Stuurman, Yann Seimbille
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-20 (2024)
Abstract Background Integrating radioactive and optical imaging techniques can facilitate the prognosis and surgical guidance for cancer patients. Using a single dual-labeled tracer ensures consistency in both imaging modalities. However, developing
Externí odkaz:
https://doaj.org/article/146801c7b094400b847694f41de23bd7
Autor:
Dylan Chapeau, Sofia Koustoulidou, Maryana Handula, Savanne Beekman, Corrina de Ridder, Debra Stuurman, Erik de Blois, Yulia Buchatskaya, Karlijn van der Schilden, Marion de Jong, Mark W. Konijnenberg, Yann Seimbille
Publikováno v:
Pharmaceuticals, Vol 16, Iss 7, p 985 (2023)
Peptide receptor radionuclide therapy (PRRT) has been applied to the treatment of neuroendocrine tumors (NETs) for over two decades. However, improvement is still needed, and targeted alpha therapy (TAT) with alpha emitters such as lead-212 (212Pb) r
Externí odkaz:
https://doaj.org/article/b8faf153cecd468bae494dab626614f5
Autor:
Timothé Vucko, Julen Ariztia, Kamal Jouad, Dylan Chapeau, Benjamin Mourot, Valérie Jouan-Hureaux, Charlotte Collet, Cédric Boura, Katalin Selmeczi, Nadia Pellegrini Moïse, Sandrine Lamandé-Langle
Publikováno v:
New Journal of Chemistry. 47:3055-3066
Efficient synthesis of a [18F]F-C-glycosyl dual imaging probe displaying a cyanine for fluorescence imaging (FLI) and a robust [18F]F–C bond for positron emission tomography (PET) imaging.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89d2b4c81a97df3b2ada2442408be55c
https://doi.org/10.1039/d2nj06134a
https://doi.org/10.1039/d2nj06134a
Autor:
Seimbille, Dylan Chapeau, Sofia Koustoulidou, Maryana Handula, Savanne Beekman, Corrina de Ridder, Debra Stuurman, Erik de Blois, Yulia Buchatskaya, Karlijn van der Schilden, Marion de Jong, Mark W. Konijnenberg, Yann
Publikováno v:
Pharmaceuticals; Volume 16; Issue 7; Pages: 985
Peptide receptor radionuclide therapy (PRRT) has been applied to the treatment of neuroendocrine tumors (NETs) for over two decades. However, improvement is still needed, and targeted alpha therapy (TAT) with alpha emitters such as lead-212 (212Pb) r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::85d2eb9a992d2392e5f70740a3476e5f